RxDoctor Payments Data

Theresa Benecki, MD

Gynecology · Brick, NJNPI 1003895418

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations.

$1,959in general payments, 2019–2025

Across 138 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$332
  • Radius Health, Inc.$281
  • Mayne Pharma Commercial LLC$228
  • Exeltis, USA Inc.$191
  • Astellas Pharma US Inc$156
  • Exact Sciences$103
  • plus $667 from 18 others

What the payments were for

  • Food & beverage$1,94599%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,959 in reported general payments places this provider in the 70th percentile of 97 gynecology providers in New Jersey.

See all gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$339,629
Medicare patients
977
Services billed
4,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab65$108,520
Estradiol217$24,796
MyrbetriqMirabegron23$16,391
PremarinEstrogens, Conjugated26$11,157
Estradiol (Twice Weekly)Estradiol30$4,130
ProgesteroneProgesterone, Micronized59$3,144
Estradiol (Once Weekly)Estradiol30$3,006
Risedronate Sodium20$2,559
ValacyclovirValacyclovir Hcl40$1,766
DivigelEstradiol11$1,756
Alendronate Sodium146$1,751
Terconazole54$1,383
Clindamycin Phosphate17$931
Clobetasol Propionate49$875
Triamcinolone Acetonide135$762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$156$16,39123 claims
PfizerPremarin$78$11,15726 claims
Vertical Pharmaceuticals, LLCDivigel$45$1,75611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 97 gynecology providers in New Jersey.

Other gynecology in Brick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →